Evidence map›Paper›PMID 25487617›Full record

ArticleTumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine2015

The negative regulators of Wnt pathway-DACH1, DKK1, and WIF1 are methylated in oral and oropharyngeal cancer and WIF1 methylation predicts shorter survival.

Jarosław Paluszczak, Joanna Sarbak, Magdalena Kostrzewska-Poczekaj, Katarzyna Kiwerska, Małgorzata Jarmuż-Szymczak, Reidar Grenman, Daniela Mielcarek-Kuchta, Wanda Baer-Dubowska

Open access · hybridAbstract read
In one paragraph

Article in Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Wnt/β-Catenin Signaling in Oral Carcinogenesis.International journal of molecular sciences · 2020
    Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. ElevatedCancer management and research · 2018
    Article
  17. Review
  18. Article
  19. Review
  20. Pentazocine Protects SN4741 Cells Against MPPFrontiers in aging neuroscience · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Jarosław PaluszczakDepartment of Pharmaceutical Biochemistry, Poznań University of Medical Sciences, ul. Święcickiego 4, 60-781, Poznań, Poland, paluszcz@ump.edu.pl.
Joanna Sarbak
Magdalena Kostrzewska-Poczekaj
Katarzyna Kiwerska
Małgorzata Jarmuż-Szymczak
Reidar Grenman
Daniela Mielcarek-Kuchta
Wanda Baer-Dubowska
Poznan University of Medical Sciences · PLInstitute of Human Genetics · PLPolish Academy of Sciences · PLTurku University Hospital · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The deregulation of Wnt signaling has recently emerged as one of the drivers of head and neck cancers. This is frequently related to the methylation of several antagonists of this pathway. This study aimed at the assessment of the profile of methylation of Wnt pathway antagonists and the determination of the prognostic value of the methylation of selected genes in oral carcinomas. The methylation of DACH1, DKK1, LKB1, PPP2R2B, RUNX3, SFRP2, and WIF-1 was analyzed in 16 oral squamous cell carcinoma cell lines using the methylation-specific polymerase chain reaction. The methylation of selected genes was further analyzed in tumor sections from 43 primary oral carcinoma patients. The analysis of oral carcinoma cell lines showed very frequent methylation of SFRP2 and WIF-1 and also a less frequent methylation of DACH1 and DKK1. On the other hand, RUNX3 was methylated only in one cell line, while LKB1 and PPP2R2B were not methylated in any of the cell lines. The biallelic methylation of DKK1 correlated with the low level of expression of this gene. Further evaluation of the methylation of DACH1, DKK1, and WIF1 in a clinical patient group confirmed the frequent methylation of WIF1 and intermediate or low frequency of methylation of DACH1 or DKK1, respectively. Importantly, the methylation of WIF-1 correlated with shorter survival in oral cancer patients. Overall, the methylation of the antagonists of Wnt pathway is frequently detected in oral squamous cell carcinomas. The methylation of WIF1 may be considered a prognostic marker in oral cancers.

Indexed as

Adaptor Proteins, Signal TransducingAdultAgedAged, 80 and overDNA MethylationEpigenesis, GeneticEye ProteinsFemaleGene Expression Regulation, NeoplasticHumansIntercellular Signaling Peptides and ProteinsMaleMiddle AgedMouth NeoplasmsOropharyngeal NeoplasmsPromoter Regions, GeneticAdaptor Proteins, Signal TransducingDACH1 protein, humanDKK1 protein, humanEye ProteinsIntercellular Signaling Peptides and ProteinsRepressor ProteinsTranscription FactorsWIF1 protein, human

Identifiers

PMID25487617
PMCPMC4428535
OpenAlexW1971820657

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.